DrugPatentWatch Database Preview
Details for Patent: 10,252,010
» See Plans and Pricing
Which drugs does patent 10,252,010 protect, and when does it expire?
Patent 10,252,010 protects XHANCE and is included in one NDA.
This patent has thirty-one patent family members in sixteen countries.
Summary for Patent: 10,252,010
| Title: | Nasal delivery devices |
| Abstract: | A nasal delivery device for and a method of delivering substance to a nasal airway of a subject, the nasal delivery device including: a mouthpiece (519) through which the subject in use exhales to cause closure of the oropharyngeal velum of the subject; a nosepiece (517) for fitting to a nostril of a subject, the nosepiece including a nozzle (549) through which substance is in use delivered to the nasal airway; and a manually-actuatable substance supply unit (520) for delivering substance through the nozzle of the nosepiece. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Sheldrake; Colin David (Wiltshire, GB) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 14/721,097 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 10,252,010
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,252,010
International Family Members for US Patent 10,252,010
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008306635 | Start Trial | |||
| Brazil | PI0817502 | Start Trial | |||
| Canada | 2701409 | Start Trial | |||
| China | 101918061 | Start Trial | |||
| Denmark | 2653183 | Start Trial | |||
| European Patent Office | 2197525 | Start Trial | |||
| European Patent Office | 2653183 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
